Search Results

OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that the Company is scheduled to release its first quarter 2024 financial results on Monday, May 6, 2024, after the market closes.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced its financial results for the first quarter ended March 31, 2024.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced its financial results for the fourth quarter and full year ended December 31, 2023.

OrthoPediatrics Corp. announced it has received the “Breakthrough Device” Designation from the Food and Drug Administration for its new eLLi surgical device, an implant designed to address severe pathology associated with Early Onset Scoliosis, which can be associated with thoracic insufficiency, a potentially life-threatening condition.